Ozempic PA · S. Kim
Draft the Humana PA for Mrs. Kim’s Ozempic. Last approval expired 4/30, she’s due for renewal.
Pulled the chart and built a draft. Step-edit requirements look satisfied. Here’s the PA letter.
Tolerated well at 0.5mg.
Hypoglycemia symptoms documented on prior sulfonylurea trial.
Drafted Justification
Letter cites her A1c, BMI, completed step therapy, and the documented sulfonylurea failure. Ready for your signature.